Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-20

Clinical Trial Update: A New Pharmacotherapy for Alcohol Dependence: Olanzapine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating olanzapine as a pharmacotherapy for alcohol dependence has been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: The Mind Research Network | Conditions: Alcohol Dependence | Phase 3 | Status: COMPLETED | Results posted: 2014-03-20